Bitcoin ETF Portfolio: Invest in Bitcoin securely and easily. Learn more

We’re licensed by the Securities Commission Malaysia (Licence <a href="https://easy.seccom.com.my:8222/entityprofile/1ca93ae1-4c0e-4c55-90e0-1850600e54f6">eCMSL/A0352/2018</a>)

Insights

We’re licensed by the Monetary Authority of Singapore (Licence no.&nbsp;<a href="https://eservices.mas.gov.sg/fid/institution/detail/201134-ASIA-WEALTH-PLATFORM-PTE-LTD">CMS100604</a>).

We’re licensed by the Securities and Futures Commission of Hong Kong (<a></a><a href="https://apps.sfc.hk/publicregWeb/corp/BQE542/details" target="_blank">CE No. BQE542</a>)

We’re licensed by the Securities and Exchange Commission (License no.&nbsp;<a></a><a href="https://market.sec.or.th/public/idisc/en/companyprofile/Intermediaries/0000031407" target="_blank">Lor Khor-0136-01</a>).

StashAway Management (DIFC) Limited is regulated by the DFSA (license number&nbsp;<a href="https://www.dfsa.ae/public-register/firms/stashaway-management-difc-limited">F006312</a>).

We discuss how the Fed's monetary stimuli impact the US dollar and the S&P 500's performance

Market Commentary: 19 August 2020

We discuss the US virus relief bill, Hong Kong's security law, and the Russian vaccine

Market Commentary: 12 August 2020

We discuss TikTok's predicament in the US, and the virus relief bill.

Market Commentary: 5 August 2020

We discuss the Fed's latest meeting and how the US stimulus package is shaping up

Market Commentary: 29 July 2020

Taking your financial future even further with $16 million USD in new funding

We’ve Raised Another $16 Million USD in New Funding

We discuss the European stimulus package and vaccine trials.

Market Commentary: 22 July 2020

We discuss Moderna's vaccine trials, and political tensions between the US and China

Market Commentary: 15 July 2020

We discuss Hong Kong's new security law and the Hong Kong dollar peg

Market Commentary: 8 July 2020

We discuss how markets are reacting to the latest economic data

Market Commentary: 1 July 2020

We discuss the US-China trade deal, the resurgence of new COVID-19 cases, and portfolio rebalancing